Zafgen halts obesity drug trial after second patient death

(Reuters) - Zafgen Inc said the U.S. Food and Drug Administration was putting a late-stage study testing its experimental obesity drug on complete hold after a second patient died during the trial.

http://ift.tt/xePdMM

from Reuters: Health News
via IFTTT